Immunobridging
Cross-source consensus on Immunobridging from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Comparisons
Highlighted claims
- Immunobridging studies compare immune responses from investigational regimens with responses from approved regimens. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
- The paper studies vaccine settings where updated regimens may be authorized without new large efficacy trials. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
- The framework is intended to estimate clinical incidence and relative vaccine efficacy curves, not only immune response differences. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data
- Regulatory or scientific immunobridging analyses can use the framework when immune correlates are validated and assumptions are credible. — Efficient estimation of cumulative incidence curves via data fusion with surrogates: application to integrated analysis of vaccine trial and immunobridging data